Boehringer Ingelheim (Italy)

Recent papers from Boehringer Ingelheim (Italy)

1. Clinical trajectory and disease progression in patients with cardio-renal-metabolic syndrome: the CaReMap observational studyEuropean Journal of Heart Failure · 2026
2. A nationwide epidemiological update on respiratory and intestinal nematodes in at-risk dogs in ItalyVeterinary Parasitology · 2026
3. Feline heartworm disease in endemic settings: an integrated diagnostic approachResearch in Veterinary Science · 2026
4. Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin AnalogueJournal of Medicinal Chemistry · 2025
5. The burden of obesity in primary care in Italy: Italian real-world overweight/obesity study (ITROS)Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · 2025
6. The awareness, characterization, and burden of Cognitive Impairment Associated with Schizophrenia (CIAS) in clinical practice: Results from a nationwide survey in ItalySchizophrenia Research Cognition · 2025
7. Current Enzooticity of Dirofilaria immitis and Angiostrongylus vasorum in Central and Southern ItalyAnimals · 2025
8. The dual GCGR/GLP‐1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selectionDiabetes Obesity and Metabolism · 2024
9. PRRS Monitoring by Processing Fluids on Italian Swine Breeding FarmsAnimals · 2023
10. Might Dog Walking Reduce the Impact of COPD on Patients’ Life?Healthcare · 2022
11. BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacySHILAP Revista de lepidopterología · 2022
12. Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb StudiesFrontiers in Oncology · 2021
13. Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung diseaseERJ Open Research · 2021
14. Pharmacovigilance and the digital world in Italy: presentation of the results of a national surveyTherapeutic Advances in Drug Safety · 2021
15. Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b studyLung Cancer · 2020
16. Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in ItalyPulmonary Therapy · 2020
17. Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational studyTherapeutic Advances in Respiratory Disease · 2019
18. Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) studySHILAP Revista de lepidopterología · 2018
19. Cost-description and multiple imputation of missing values: theSATisfaction and adherence to COPD treatment(SAT) studyGlobal & Regional Health Technology Assessment · 2018
20. Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in VivoACS Medicinal Chemistry Letters · 2017